Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Bio Essence (BIOE) EBT Margin (2020 - 2025)

Historic EBT Margin for Bio Essence (BIOE) over the last 6 years, with Q3 2025 value amounting to 9.5%.

  • Bio Essence's EBT Margin rose 9000600.0% to 9.5% in Q3 2025 from the same period last year, while for Sep 2025 it was 28.22%, marking a year-over-year increase of 13463600.0%. This contributed to the annual value of 483.09% for FY2024, which is 4100200.0% down from last year.
  • According to the latest figures from Q3 2025, Bio Essence's EBT Margin is 9.5%, which was up 9000600.0% from 23.41% recorded in Q2 2025.
  • In the past 5 years, Bio Essence's EBT Margin registered a high of 89.25% during Q4 2023, and its lowest value of 927.27% during Q1 2025.
  • For the 5-year period, Bio Essence's EBT Margin averaged around 157.17%, with its median value being 67.47% (2023).
  • Data for Bio Essence's EBT Margin shows a peak YoY increase of 9000600bps (in 2025) and a maximum YoY decrease of -8473400bps (in 2025) over the last 5 years.
  • Over the past 5 years, Bio Essence's EBT Margin (Quarter) stood at 42.54% in 2021, then grew by 3bps to 41.19% in 2022, then surged by 317bps to 89.25% in 2023, then plummeted by -121bps to 18.68% in 2024, then soared by 151bps to 9.5% in 2025.
  • Its EBT Margin stands at 9.5% for Q3 2025, versus 23.41% for Q2 2025 and 927.27% for Q1 2025.